Ian Brown
Director/Board Member at BIOLIDICS LIMITED
Profile
Ian David Brown is currently the Chief Executive Officer & Managing Director at Yallingup Ventures Pty Ltd., the Independent Chairman at Rex Ortho Pty Ltd, the Independent Non-Executive Director at Biolidics Ltd., and a Director at Cytomatrix Pty Ltd.
He previously served as the Chief Executive Officer of RepRegen Ltd.
from 2009 to 2011 and Avanti Capital from 2007 to 2009.
He was also the Independent Chairman at Intergrain Pty Ltd.
from 2014 to 2023 and Omniblend Innovation Pty Ltd.
He held the position of Chief Operating Officer & Executive Director at CyGenics Ltd.
from 2001 to 2007.
Mr. Brown has an MBA from The University of Queensland, which he obtained in 2007.
Ian Brown active positions
Companies | Position | Start |
---|---|---|
BIOLIDICS LIMITED | Director/Board Member | 2021-06-13 |
Yallingup Ventures Pty Ltd. | Chief Executive Officer | 2010-12-31 |
Rex Ortho Pty Ltd
Rex Ortho Pty Ltd Medical SpecialtiesHealth Technology Rex Ortho Pty Ltd is an Australian company that specializes in the manufacturing and supply of orthopedic equipment. | Chairman | - |
Cytomatrix Pty Ltd.
Cytomatrix Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of SK3 Group, Inc., Cytomatrix Pty Ltd. is an Australian company that researches and develops novel cell culture scaffolds and systems for clinical applications. The private company is based in Waurn Ponds, Australia. Cytomatrix was acquired by Healthcare of Today, Inc. on July 21, 2010. | Director/Board Member | - |
Former positions of Ian Brown
Companies | Position | End |
---|---|---|
Intergrain Pty Ltd.
Intergrain Pty Ltd. Agricultural Commodities/MillingProcess Industries Intergrain Pty Ltd. provides crop breeding services. It offers wheat and barley breeding programs in cereal growing areas of Australia.The company was founded in October 2007 and is headquartered in Bibra Lake, Australia. | Chairman | 2023-04-28 |
RECCE PHARMACEUTICALS LTD | Director/Board Member | 2016-06-22 |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services RepRegen Ltd. develops synthetic, biologically-active and tissue engineering products. Its smart biomaterials are designed both to support and to improve cellular growth in vivo. The firm is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and regrow tissue in the body. RepRegen's first platform is focused on bone and other (hard) tissue, whereas the second platform is focused on muscle and other (soft) tissue. The company was founded in June 2006 and is headquartered in London, GB. | Chief Executive Officer | 2010-12-31 |
Avanti Capital
Avanti Capital Investment ManagersFinance Avanti Capital is the private equity operating division of independent investment firm Avanti Capital Plc (LSE: AVA), headquartered in London. | Chief Executive Officer | 2008-12-31 |
CyGenics Ltd. | Chief Operating Officer | 2006-12-31 |
Training of Ian Brown
The University of Queensland | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
RECCE PHARMACEUTICALS LTD | Health Technology |
BIOLIDICS LIMITED | Health Technology |
Private companies | 11 |
---|---|
CyGenics Ltd. | Commercial Services |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services RepRegen Ltd. develops synthetic, biologically-active and tissue engineering products. Its smart biomaterials are designed both to support and to improve cellular growth in vivo. The firm is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and regrow tissue in the body. RepRegen's first platform is focused on bone and other (hard) tissue, whereas the second platform is focused on muscle and other (soft) tissue. The company was founded in June 2006 and is headquartered in London, GB. | Health Services |
Avanti Capital
Avanti Capital Investment ManagersFinance Avanti Capital is the private equity operating division of independent investment firm Avanti Capital Plc (LSE: AVA), headquartered in London. | Finance |
Cytomatrix Pty Ltd.
Cytomatrix Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of SK3 Group, Inc., Cytomatrix Pty Ltd. is an Australian company that researches and develops novel cell culture scaffolds and systems for clinical applications. The private company is based in Waurn Ponds, Australia. Cytomatrix was acquired by Healthcare of Today, Inc. on July 21, 2010. | Commercial Services |
Intergrain Pty Ltd.
Intergrain Pty Ltd. Agricultural Commodities/MillingProcess Industries Intergrain Pty Ltd. provides crop breeding services. It offers wheat and barley breeding programs in cereal growing areas of Australia.The company was founded in October 2007 and is headquartered in Bibra Lake, Australia. | Process Industries |
Activ Foundation, Inc. | |
Western Australian Angel Investors, Inc.
Western Australian Angel Investors, Inc. Financial ConglomeratesFinance Western Australian Angel Investors, Inc. is engaged in providing investment services. It create awareness of angel investing as an alternative asset class, educates investors on practice for investing in local early-stage ventures, generates efficient and deal-flow for early-stage Investors, and complement diverse and innovation ecosystem. The company was founded by Jamie Davison and Paul Kristensen in 2010 and is headquartered in Melville, Australia. | Finance |
Omniblend Innovation Pty Ltd.
Omniblend Innovation Pty Ltd. Pharmaceuticals: OtherHealth Technology Omniblend Innovation Pty Ltd. specializes in food grade products. It provides the food product which creates and specialized food grade products that can be used by people with diabetes and other health conditions. The firm helps people with diabetes and pre-diabetes are advised to consult with a care provider to analyze current eating patterns and select those meals where a pre-meal drink may be helpful. The company was founded in 2010 and is headquartered in Brooklyn, Australia. | Health Technology |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Health Technology |
Rex Ortho Pty Ltd
Rex Ortho Pty Ltd Medical SpecialtiesHealth Technology Rex Ortho Pty Ltd is an Australian company that specializes in the manufacturing and supply of orthopedic equipment. | Health Technology |
Yallingup Ventures Pty Ltd. |
- Stock Market
- Insiders
- Ian Brown